Pages that link to "Q33381256"
Jump to navigation
Jump to search
The following pages link to Heparin-induced thrombocytopenia: a historical perspective (Q33381256):
Displaying 50 items.
- Heparin-induced thrombocytopenia in solid organ transplant recipients: The current scientific knowledge (Q26751442) (← links)
- Heparin induced thrombocytopenia in critically ill: Diagnostic dilemmas and management conundrums (Q26799395) (← links)
- HITlights: a career perspective on heparin-induced thrombocytopenia (Q26828351) (← links)
- Heparin modulates the conformation and signaling of platelet integrin αIIbβ3 (Q30513893) (← links)
- Severe bleeding secondary to misuse of fondaparinux: a case report (Q33385457) (← links)
- Heparin-induced thrombocytopenia: a renal perspective (Q33385560) (← links)
- Heparin and oversulfated heparin byproduct induce thrombin generation through contact system activation in plasma of patients with HIT. (Q33389514) (← links)
- Molecular mechanism underlines heparin-induced thrombocytopenia and thrombosis (Q33391708) (← links)
- Fondaparinux: does it cause HIT? can it treat HIT? (Q33392864) (← links)
- Bivalirudin utilization in cardiac surgery: shifting anticoagulation from indirect to direct thrombin inhibition (Q33393161) (← links)
- HIT Heparin-Induced Thrombocytopenia (Q33395316) (← links)
- Pentadecapeptide BPC 157 reduces bleeding time and thrombocytopenia after amputation in rats treated with heparin, warfarin or aspirin (Q33396718) (← links)
- The Syk-kinase inhibitor R406 impairs platelet activation and monocyte tissue factor expression triggered by heparin-PF4 complex directed antibodies (Q33396756) (← links)
- Donor heparinization is not a contraindication to liver transplantation even in recipients with acute heparin-induced thrombocytopenia type II: a case report and review of the literature (Q33396973) (← links)
- Anti-PF4/heparin antibodies are associated with arteriovenous fistula thrombosis in non-diabetic hemodialysis patients (Q33397873) (← links)
- Rational design and characterization of platelet factor 4 antagonists for the study of heparin-induced thrombocytopenia. (Q33400431) (← links)
- Allograft coronary artery thrombosis: a case report of early cardiac allograft left ventricular myocardial infarction (Q33402799) (← links)
- Why is the platelet count low: should I be concerned about heparin-induced thrombocytopenia? (Q33404176) (← links)
- Emphasis on the Role of PF4 in the Incidence, Pathophysiology and Treatment of Heparin Induced Thrombocytopenia (Q33406904) (← links)
- Heparin induced thrombocytopenia: review (Q33410083) (← links)
- Heparin-induced thrombocytopenia and thrombosis as an under-diagnosed cause of flap failure in heparin-naive patients: a case report and systematic review of the literature (Q33411050) (← links)
- Drug-induced thrombocytopenia in the critically ill: a case-control study (Q33414170) (← links)
- Update on argatroban for the prophylaxis and treatment of heparin-induced thrombocytopenia type II (Q33417258) (← links)
- The management of abnormal haemostasis in the ICU. (Q33418970) (← links)
- Pitfalls in the diagnosis of heparin-Induced thrombocytopenia: A 6-year experience from a reference laboratory (Q33421456) (← links)
- From clinical reasoning to effective clinical decision making-new training methods (Q33422677) (← links)
- Current management of heparin-induced thrombocytopenia (Q33425840) (← links)
- The platelet Fc receptor, FcγRIIa (Q33427010) (← links)
- Bilateral adrenal haemorrhage: a cause of haemodynamic collapse in heparin-induced thrombocytopaenia (Q33430636) (← links)
- A case of enoxaparin-induced thrombocytopaenia during treatment of acute myocardial infarction (Q33431523) (← links)
- Screening frequency, incidence and pattern of heparin-induced thrombocytopenia syndrome at a large tertiary institution (Q33431708) (← links)
- A high-value cost conscious approach to minimize heparin induced thrombocytopenia antibody (HITAb) testing using the 4T score (Q33433623) (← links)
- Heparin-induced thrombocytopenia among patients of a comprehensive cancer center (Q33434343) (← links)
- The association of anti-platelet factor 4/heparin antibodies with early and delayed thromboembolism after cardiac surgery (Q33435819) (← links)
- A Case of Heparin-Induced Thrombocytopenia Type 2 after Repair of Juxtarenal Abdominal Aortic Aneurysm (Q33437954) (← links)
- Characterizing the microstructure of heparin and heparan sulfate using N-sulfoglucosamine 1H and 15N NMR chemical shift analysis (Q34512911) (← links)
- Heparin promotes platelet responsiveness by potentiating αIIbβ3-mediated outside-in signaling (Q35001659) (← links)
- Historical perspective and future directions in platelet research (Q35185593) (← links)
- Thrombophilia Associated with Anti-DFS70 Autoantibodies (Q35784744) (← links)
- Anticoagulant activity of a unique sulfated pyranosic (1->3)-β-L-arabinan through direct interaction with thrombin (Q36508588) (← links)
- The design and synthesis of new synthetic low-molecular-weight heparins (Q37004231) (← links)
- Multifunctional silk-heparin biomaterials for vascular tissue engineering applications (Q37414159) (← links)
- Anti-Platelet Factor 4/Heparin Antibody Plays a Significant Role in Progression of Arterial Stiffness among Hemodialysis Patients. (Q37719020) (← links)
- Chemoenzymatic synthesis of the next generation of ultralow MW heparin therapeutics (Q37990946) (← links)
- In Vivo Chemical Sensors: Role of Biocompatibility on Performance and Utility. (Q39096236) (← links)
- Targeting heparin and heparan sulfate protein interactions. (Q39399937) (← links)
- Tissue factor-mediated activation of the prothrombin complex concentrate (PCC) is differently inhibited by dabigatran, rivaroxaban, and apixaban: potential clinical implication (Q45895798) (← links)
- Favorable Maternal and Fetal Effects of Danshensu in an Experimental Mice Model of Preeclampsia (Q46329620) (← links)
- Fondaparinux is effective for acute portal vein thrombosis in decompensated cirrhotic patients (Q46977069) (← links)
- NHLBI state of the science symposium in therapeutic apheresis: Knowledge gaps and research opportunities in the area of hematology-oncology (Q48491917) (← links)